Spratt, Daniel E.
Cleveland Clinic · University Hospitals Seidman Cancer Center · Case Comprehensive Cancer Center
14 papers on CoChatORCID 0000-0002-5973-4741
Most cited papers
- Verified
Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer
Quigley, D. A., Dang, H. X., Zhao, S. G., Lloyd, P., Aggarwal, R., Alumkal, J. J., Foye, A., Kothari, V., Perry, M. D., Bailey, A. M., et al. (2018) · Cell
Prostate Cancer Treatment and ResearchCancer Genomics and Diagnostics
Cited by 733
- Verified
Racial/ethnic disparities in genomic sequencing
Spratt, D. E., Chan, T., Waldron, L., Speers, C., Feng, F. Y., Ogunwobi, O. O., & Osborne, J. R. (2016) · JAMA Oncology
Cancer Genomics and DiagnosticsRace, Genetics, and Society
Cited by 375
- Verified
Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials
Esteva, A., Feng, J., van der Wal, D., Huang, S.-C., Simko, J. P., DeVries, S., Chen, E., Schaeffer, E. M., Morgan, T. M., Sun, Y., et al. (2022) · npj Digital Medicine
Radiomics and Machine Learning in Medical ImagingAI in cancer detection
Cited by 217
- Verified
Cancer misinformation and harmful information on Facebook and other social media: a brief report
Johnson, S. B., Parsons, M., Dorff, T., Moran, M. S., Ward, J. H., Cohen, S. A., Akerley, W., Bauman, J., Hubbard, J., Spratt, D. E., et al. (2022) · JNCI: Journal of the National Cancer Institute
Misinformation and Its ImpactsSocial Media in Health Education
Cited by 210
- Verified
High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program
Labbé, D. P., Zadra, G., Yang, M., Reyes, J. M., Lin, C. Y., Cacciatore, S., Ebot, E. M., Creech, A. L., Giunchi, F., Fiorentino, M., et al. (2019) · Nature Communications
Cancer, Lipids, and MetabolismProstate Cancer Treatment and Research
Cited by 174
- Verified
Artificial intelligence predictive model for hormone therapy use in prostate cancer
Spratt, D. E., Tang, S., Sun, Y., Huang, H.-C., Chen, E., Mohamad, O., Armstrong, A. J., Tward, J. D., Nguyen, P. L., Lang, J. M., et al. (2023) · NEJM Evidence
Prostate Cancer Diagnosis and TreatmentRadiomics and Machine Learning in Medical Imaging
Cited by 153
- Verified
Prostate Cancer, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology
Spratt, D. E., Srinivas, S., Adra, N., Ahmed, B., An, Y., Bitting, R., Chapin, B., Cheng, H. H., Cho, S. Y., D’Amico, A. V., et al. (2025) · Journal of the National Comprehensive Cancer Network
Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and Treatment
Cited by 146
- Verified
Management of patients with advanced prostate cancer: report from the Advanced Prostate Cancer Consensus Conference 2021
Gillessen, S., Armstrong, A., Attard, G., Beer, T. M., Beltran, H., Bjartell, A., Bossi, A., Briganti, A., Bristow, R. G., Bulbul, M., et al. (2022) · European Urology
Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and Treatment
Cited by 130
- Verified
Racial differences in genomic profiling of prostate cancer
Mahal, B. A., Alshalalfa, M., Kensler, K. H., Chowdhury-Paulino, I., Kantoff, P., Mucci, L. A., Schaeffer, E. M., Spratt, D., Yamoah, K., Nguyen, P. L., et al. (2020) · New England Journal of Medicine
Prostate Cancer Treatment and ResearchCancer Genomics and Diagnostics
Cited by 126
- Verified
Validation of the Decipher genomic classifier in patients receiving salvage radiotherapy without hormone therapy after radical prostatectomy – an ancillary study of the SAKK 09/10 randomized clinical trial
Dal Pra, A., Ghadjar, P., Hayoz, S., Liu, V. Y. T., Spratt, D. E., Thompson, D. J. S., Davicioni, E., Huang, H.-C., Zhao, X., Liu, Y., et al. (2022) · Annals of Oncology
Prostate Cancer Diagnosis and TreatmentBreast Cancer Treatment Studies
Cited by 65
- Verified
Germline and somatic genomic testing for metastatic prostate cancer: ASCO guideline
Yu, E. Y., Rumble, R. B., Agarwal, N., Cheng, H. H., Eggener, S. E., Bitting, R. L., Beltran, H., Giri, V. N., Spratt, D., Mahal, B., et al. (2025) · Journal of Clinical Oncology
Prostate Cancer Treatment and ResearchCancer Genomics and Diagnostics
Cited by 64
- Verified
Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial
Spratt, D. E., Liu, V. Y. T., Michalski, J., Davicioni, E., Berlin, A., Simko, J. P., Efstathiou, J. A., Tran, P. T., Sandler, H. M., Hall, W. A., et al. (2023) · International Journal of Radiation Oncology*Biology*Physics
Prostate Cancer Diagnosis and TreatmentBreast Cancer Treatment Studies
Cited by 45
- Verified
External validation of a digital pathology-based multimodal artificial intelligence architecture in the NRG/RTOG 9902 phase 3 trial
Ross, A. E., Zhang, J., Huang, H.-C., Yamashita, R., Keim-Malpass, J., Simko, J. P., DeVries, S., Morgan, T. M., Souhami, L., Dobelbower, M. C., et al. (2024) · European Urology Oncology
AI in cancer detectionRadiomics and Machine Learning in Medical Imaging
Cited by 35
- Verified
Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical Prostatectomy
Karnes, R. J., Sharma, V., Choeurng, V., Ashab, H. A.-D., Erho, N., Alshalalfa, M., Trock, B., Ross, A., Yousefi, K., Tsai, H., et al. (2018) · Clinical Cancer Research
Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and Treatment
Cited by 30
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free